Authors:
Ralhan, R
Agarwal, S
Nath, N
Mathur, M
Wasylyk, B
Srivastava, A
Citation: R. Ralhan et al., Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population, ORAL ONCOL, 37(3), 2001, pp. 243-250
Authors:
Gewirtz, DA
Di, YM
Randolph, JK
Jain, PT
Valerie, K
Bullock, S
Nath, N
Chellappan, SP
Citation: Da. Gewirtz et al., Rb dephosphorylation and suppression of E2F activity in human breast tumorcells exposed to a pharmacological concentration of estradiol, ARCH BIOCH, 388(2), 2001, pp. 243-252
Citation: N. Nath et A. Chilkoti, Interfacial phase transition of an environmentally responsive elastin biopolymer adsorbed on functionalized gold nanoparticles studied by colloidal surface plasmon resonance, J AM CHEM S, 123(34), 2001, pp. 8197-8202
Authors:
Bahl, R
Arora, S
Nath, N
Mathur, M
Shukla, NK
Ralhan, R
Citation: R. Bahl et al., Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer, ONCOGENE, 19(3), 2000, pp. 323-328
Citation: Ma. Mir et N. Nath, Protein fortification of mango bar using soy protein concentrate and coconut powder, J FD SCI M, 37(5), 2000, pp. 525-528
Citation: S. Wang et al., Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function, ONCOGENE, 18(23), 1999, pp. 3501-3510
Citation: S. Wang et al., Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals, MOL CELL B, 19(11), 1999, pp. 7447-7460
Citation: S. Wang et al., Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases, EMBO J, 18(6), 1999, pp. 1559-1570
Citation: N. Nath et al., HLA class I-mediated induction of cell proliferation involves cyclin E-mediated inactivation of Rb function and induction of E2F activity, J IMMUNOL, 162(9), 1999, pp. 5351-5358
Authors:
Ralhan, R
Swain, RK
Agarwal, S
Kaur, J
Nath, N
Sarkar, G
Mathur, M
Shukla, NK
Citation: R. Ralhan et al., P-glycoprotein is positively correlated with p53 in human oral pre-malignant and malignant lesions and is associated with poor prognosis, INT J CANC, 84(1), 1999, pp. 80-85